Tiago Fauth
Stock Analyst at Raymond James
(4.45)
# 1,097
Out of 4,408 analysts
298
Total ratings
48%
Success rate
11.9%
Average return
Main Sectors:
Stocks Rated by Tiago Fauth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintained: Buy | $200 → $185 | $97.46 | +89.82% | 23 | May 8, 2026 | |
| PTCT PTC Therapeutics | Maintained: Buy | $108 → $95 | $76.77 | +23.75% | 22 | May 8, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $227 → $239 | $230.59 | +3.65% | 2 | May 6, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Hold | $395 → $377 | $287.80 | +30.99% | 14 | May 1, 2026 | |
| IONS Ionis Pharmaceuticals | Initiated Coverage: Buy | $104 | $73.96 | +40.62% | 1 | Apr 10, 2026 | |
| UTHR United Therapeutics | Initiated Coverage: Buy | $414 → $700 | $549.57 | +27.37% | 26 | Apr 9, 2026 | |
| MIST Milestone Pharmaceuticals | Initiated Coverage: Buy | $6 | $1.31 | +358.02% | 1 | Apr 9, 2026 | |
| RAPP Rapport Therapeutics | Initiated Coverage: Buy | $66 | $38.26 | +72.50% | 1 | Apr 9, 2026 | |
| PRAX Praxis Precision Medicines | Initiated Coverage: Buy | $815 | $264.54 | +208.08% | 1 | Apr 8, 2026 | |
| KROS Keros Therapeutics | Maintained: Buy | $26 → $20 | $10.24 | +95.31% | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $7 | $4.00 | +75.00% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $76 | $68.00 | +11.76% | 17 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $18 | $6.00 | +200.00% | 11 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $31 | $71.80 | -56.82% | 6 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $29.39 | +243.65% | 7 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $88 → $65 | $25.38 | +156.11% | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $5.33 | n/a | 4 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $91 | $70.09 | n/a | 5 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $1.14 | n/a | 9 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $12.76 | n/a | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $35 → $70 | $16.10 | n/a | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 | $55.65 | n/a | 8 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $16.30 | n/a | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $89 | $223.29 | n/a | 22 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $49.91 | n/a | 4 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $26 | $9.54 | n/a | 6 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $28 | $5.26 | n/a | 9 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 | $1.62 | n/a | 6 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $3.62 | n/a | 7 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $34 | $1.58 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $20.07 | n/a | 3 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $2.11 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 → $13 | $2.46 | n/a | 4 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $14 | $1.74 | n/a | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $14 | $7.27 | n/a | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $340 → $319 | $884.20 | n/a | 9 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $12 → $7 | $33.44 | n/a | 7 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $265 → $259 | $350.53 | n/a | 2 | Apr 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €240.00 | $757.80 | n/a | 1 | Oct 22, 2020 |
Insmed
May 8, 2026
Maintained: Buy
Price Target: $200 → $185
Current: $97.46
Upside: +89.82%
PTC Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $108 → $95
Current: $76.77
Upside: +23.75%
Jazz Pharmaceuticals
May 6, 2026
Maintained: Buy
Price Target: $227 → $239
Current: $230.59
Upside: +3.65%
Alnylam Pharmaceuticals
May 1, 2026
Maintained: Hold
Price Target: $395 → $377
Current: $287.80
Upside: +30.99%
Ionis Pharmaceuticals
Apr 10, 2026
Initiated Coverage: Buy
Price Target: $104
Current: $73.96
Upside: +40.62%
United Therapeutics
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $414 → $700
Current: $549.57
Upside: +27.37%
Milestone Pharmaceuticals
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $1.31
Upside: +358.02%
Rapport Therapeutics
Apr 9, 2026
Initiated Coverage: Buy
Price Target: $66
Current: $38.26
Upside: +72.50%
Praxis Precision Medicines
Apr 8, 2026
Initiated Coverage: Buy
Price Target: $815
Current: $264.54
Upside: +208.08%
Keros Therapeutics
Mar 5, 2026
Maintained: Buy
Price Target: $26 → $20
Current: $10.24
Upside: +95.31%
Feb 27, 2026
Maintained: Buy
Price Target: $10 → $7
Current: $4.00
Upside: +75.00%
Sep 11, 2025
Maintained: Buy
Price Target: $76
Current: $68.00
Upside: +11.76%
Sep 4, 2025
Maintained: Buy
Price Target: $21 → $18
Current: $6.00
Upside: +200.00%
Aug 13, 2025
Maintained: Buy
Price Target: $25 → $31
Current: $71.80
Upside: -56.82%
Aug 7, 2025
Maintained: Buy
Price Target: $101
Current: $29.39
Upside: +243.65%
Jul 9, 2025
Maintained: Buy
Price Target: $88 → $65
Current: $25.38
Upside: +156.11%
May 28, 2025
Maintained: Buy
Price Target: $8 → $7
Current: $5.33
Upside: n/a
May 8, 2025
Maintained: Buy
Price Target: $91
Current: $70.09
Upside: n/a
Mar 4, 2025
Maintained: Hold
Price Target: $4 → $3
Current: $1.14
Upside: n/a
Aug 22, 2024
Initiated Coverage: Hold
Price Target: $16
Current: $12.76
Upside: n/a
Jun 17, 2024
Downgraded: Hold
Price Target: $35 → $70
Current: $16.10
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $120
Current: $55.65
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $51
Current: $16.30
Upside: n/a
Jun 13, 2023
Initiated Coverage: Hold
Price Target: $89
Current: $223.29
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $4
Current: $49.91
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $29 → $26
Current: $9.54
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $34 → $28
Current: $5.26
Upside: n/a
Apr 5, 2023
Reiterated: Sell
Price Target: $2
Current: $1.62
Upside: n/a
Mar 24, 2023
Reiterated: Hold
Price Target: $8
Current: $3.62
Upside: n/a
Mar 10, 2023
Maintained: Buy
Price Target: $38 → $34
Current: $1.58
Upside: n/a
Mar 10, 2023
Reiterated: Buy
Price Target: $7 → $6
Current: $20.07
Upside: n/a
Dec 16, 2022
Initiated Coverage: Buy
Price Target: $13
Current: $2.11
Upside: n/a
Nov 17, 2022
Downgraded: Hold
Price Target: $33 → $13
Current: $2.46
Upside: n/a
Aug 15, 2022
Maintained: Buy
Price Target: $19 → $14
Current: $1.74
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $28 → $14
Current: $7.27
Upside: n/a
Mar 3, 2022
Maintained: Hold
Price Target: $340 → $319
Current: $884.20
Upside: n/a
Aug 2, 2021
Downgraded: Sell
Price Target: $12 → $7
Current: $33.44
Upside: n/a
Apr 28, 2021
Maintained: Buy
Price Target: $265 → $259
Current: $350.53
Upside: n/a
Oct 22, 2020
Maintained: Hold
Price Target: €240.00
Current: $757.80
Upside: n/a